Fri, Dec 26, 2014, 9:43 AM EST - U.S. Markets close in 6 hrs 17 mins

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • johnmatson6l johnmatson6l Apr 7, 2014 10:19 AM Flag

    Insmed Down on Disappointing Arikayce Results Zacks By Zacks Equity Research

    Insmed Down on Disappointing Arikayce Results
    Zacks By Zacks Equity Research
    r the company announced that its candidate, Arikayce, failed to meet the primary objective in a phase II study (n=90). The candidate is being developed for the treatment of patients suffering from treatment resistant nontuberculous mycobacterial (:NTM) lung infections.

    The primary objective of the phase II study was a semi-quantitative measurement of the difference in mycobacterial density on a seven-point scale from baseline to the end of the randomized portion of the study

 
INSM
15.3916+0.1016(+0.66%)9:39 AMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.